title: The selective therapeutic apheresis procedures.
abstract: Selective apheresis procedures have been developed to target specific molecules, antibodies, or cellular elements in a variety of diseases. The advantage of the selective apheresis procedures over conventional therapeutic plasmapheresis is preservation of other essential plasma components such as albumin, immunoglobulins, and clotting factors. These procedures are more commonly employed in Europe and Japan, and few are available in the USA. Apheresis procedures discussed in this review include the various technologies available for low-density lipoprotein (LDL) apheresis, double filtration plasmapheresis (DFPP), cryofiltration, immunoadsorption procedures, adsorption resins that process plasma, extracorporeal photopheresis, and leukocyte apheresis.
authors: Therapeutic Apheresis Program, Department of Medicine, Division of Nephrology and Hypertension, University of California San Diego Medical Center, San Diego, CA, USA. dmward@ucsd.edu
authors: Amber P
authors: AP
authors: Sanchez
authors: Robyn
authors: R
authors: Cunard
authors: David M
authors: DM
authors: Ward
mesh_terms: D001323:Autoantibodies / Q000097:blood; D001773:Blood Cells; D001781:Blood Component Removal / Q000295:instrumentation / Q000379:methods*; D003450:Cryoglobulins; D005374:Filtration / Q000295:instrumentation / Q000379:methods; D006801:Humans; D055767:Immobilized Proteins; D007136:Immunoglobulins / Q000097:blood; D007163:Immunosorbent Techniques / Q000295:instrumentation; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D017893:Photopheresis / Q000295:instrumentation / Q000379:methods; D012117:Resins, Synthetic; D013205:Staphylococcal Protein A; D014481:United States
chemical_list: D001323:Autoantibodies; D003450:Cryoglobulins; D055767:Immobilized Proteins; D007136:Immunoglobulins; D008055:Lipids; D008074:Lipoproteins; D012117:Resins, Synthetic; D013205:Staphylococcal Protein A